Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Xeloda
Routinely available
SMC (34/03)
01/01/2000
Indication
Metastatic breast cancer
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
Tablets
Comments
Included in the Formulary.